benralizumab (fasenra) Report issue

Biologics mAb Approved FDA First in Class
AACT ChEMBL DrugBank Drugs@FDA
Back

Drug Pricing Summary

VA NC

$2500.0000

AUS PBS

$2567.0183

VA Big4

$3700.3500 - $3728.0300

VA FSS

$4937.8700 - $5029.6700

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
benralizumab 30 mg / 1 mL (1 mL INJECTION) $2500.0000 VA NC
  • FASENRA (1)
    		•  AstraZeneca Pharmaceuticals, LP
  • FASENRA (1)
    		•  AstraZeneca Pharmaceuticals, LP
    benralizumab 30 mg / 1 mL (1 mL INJECTION) $2567.0183 AUS PBS generic
  • Fasenra (1)
    		•  AstraZeneca Pty Ltd
  • Fasenra Pen (1)
    		•  AstraZeneca Pty Ltd
    benralizumab 30 mg / 1 mL (1 mL INJECTION) $3700.3500 VA Big4
  • FASENRA (1)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    benralizumab 30 mg / 1 mL (1 mL INJECTION) $3728.0300 VA Big4
  • FASENRA (1)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    benralizumab 30 mg / 1 mL (1 mL INJECTION) $4937.8700 VA FSS
  • FASENRA (1)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    benralizumab 30 mg / 1 mL (1 mL INJECTION) $5029.6700 VA FSS
  • FASENRA (1)
    		•  ASTRAZENECA PHARMACEUTICALS LP

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue